These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10476135)

  • 1. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
    Harris JL; Maguire D
    J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
    Bagnall HA; Gomperts E; Atkinson JB
    Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase administration in pediatric patients with occluded central venous catheters.
    Wachs T
    J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase efficacy in the restoration of hemodialysis catheter function.
    Meers C; Toffelmire EB
    J CANNT; 1998; 8(2):17-9. PubMed ID: 9807329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predisposing factors, prevention, and management of central venous catheter occlusions.
    Krzywda EA
    J Intraven Nurs; 1999; 22(6 Suppl):S11-7. PubMed ID: 10865603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase therapy in neonates with catheter related central venous thrombosis.
    Wever ML; Liem KD; Geven WB; Tanke RB
    Thromb Haemost; 1995 Feb; 73(2):180-5. PubMed ID: 7792727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
    Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
    J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clot lysis for thrombosed central venous catheters in pediatric patients.
    Kellam B; Fraze D; Kanarek KS
    J Perinatol; 1987; 7(3):242-4. PubMed ID: 3504465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of obstruction and thrombosis due to central venous catheterization].
    Leititis JU
    Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of central venous access device occlusion. Implications for nursing practice.
    Bagnall-Reeb H
    J Intraven Nurs; 1998; 21(5 Suppl):S115-21. PubMed ID: 9814286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of central venous catheter occlusions and repairs.
    Reed T; Phillips S
    J Intraven Nurs; 1996; 19(6):289-94. PubMed ID: 9060354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous catheter occlusion.
    Richardson D
    Oncol Nurs Forum; 1999 May; 26(4):683. PubMed ID: 10337640
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator for central venous access device occlusion.
    Hooke C
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters.
    Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP
    Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
    Mayo DJ; Pearson DC
    Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study.
    Rummel MA; Donnelly PJ; Fortenbaugh CC
    Clin J Oncol Nurs; 2001; 5(6):261-5. PubMed ID: 11899627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
    Davies J; Casey J; Li C; Crowe AV; McClelland P
    J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
    Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
    Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilution of urokinase used to treat thrombus formation in central venous catheters.
    Wiseman KC
    ANNA J; 1997 Aug; 24(4):457-8. PubMed ID: 9325699
    [No Abstract]   [Full Text] [Related]  

  • 20. Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients.
    Simon A; Bode U; Lieber K; Beutel K; Fleischhack G
    Am J Infect Control; 2008 Feb; 36(1):54-8. PubMed ID: 18241737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.